Targeted DNA sequencing for TP53, RAS, BRAF, ALK, and NF1 of 30 formalin-fixed paraffin-embedded (FFPE) ATC tumor samples by Latteyer et al., showed that 28/30 tested samples carried at least one of the tested mutations [144]. The gene discussed is BRAF; the disease is neoplasm.